ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,092Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 3001

$1.52M Total Retail Price of All Prescriptions

Rank: 35 out of 3001

681 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 681 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 681 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 19,377 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
AMLODIPINE BESYLATE 988 758 1 5
LISINOPRIL 948 707 2 2
HYDROCODONE-ACETAMINOPHEN 833 617 S3 3 7
LEVOTHYROXINE SODIUM 749 604 4 3
FUROSEMIDE 722 589 5 6
METOPROLOL TARTRATE 686 555 6 8
OMEPRAZOLE 636 437 7 4
POTASSIUM CHLORIDE 612 424 8 15
SIMVASTATIN 596 434 9 1
METFORMIN HCL 495 328 10 9
GABAPENTIN 446 280 11 14
HYDROCHLOROTHIAZIDE 371 225 12 10
NEXIUM 363 248 13 23
TRAMADOL HCL 334 229 14 17
CARVEDILOL 315 270 15 25
CITALOPRAM HBR 315 284 15 16
WARFARIN SODIUM 312 294 17 12
CLOPIDOGREL 292 246 18 28
LOSARTAN POTASSIUM 285 238 19 21
TAMSULOSIN HCL 261 219 20 29
ENALAPRIL MALEATE 222 188 21 83
MIRTAZAPINE 220 207 22 44
SERTRALINE HCL 212 139 23 20
OXYCODONE-ACETAMINOPHEN 210 156 S2 24 32
PLAVIX 199 171 25 46
TRAZODONE HCL 196 101 26 37
ZOLPIDEM TARTRATE 194 127 27 24
CYMBALTA 192 92 28 53
FAMOTIDINE 190 166 29 68
NAMENDA 188 184 30 40
ATORVASTATIN CALCIUM 185 150 31 11
DIVALPROEX SODIUM 176 144 32 70
KLOR-CON M20 172 133 33 52
DONEPEZIL HCL 170 163 34 27
PROAIR HFA 164 85 35 30
RANITIDINE HCL 157 111 36 41
LYRICA 155 71 37 87
GLIMEPIRIDE 152 46 38 31
FLUTICASONE PROPIONATE 150 109 39 42
ATENOLOL 148 142 40 18
CLONIDINE HCL 147 98 41 64
TIZANIDINE HCL 147 63 41 101
ACTOS 147 107 41 113
LANTUS SOLOSTAR 146 128 44 80
DIOVAN 142 115 45 50
AMITRIPTYLINE HCL 134 89 R 46 85
PRAVASTATIN SODIUM 132 121 47 13
RISPERIDONE 129 65 48 63
QUETIAPINE FUMARATE 113 81 49 66
CRESTOR 110 85 50 33
JANUVIA 109 94 51 54
PROMETHAZINE HCL 106 58 R 52 93
PEN NEEDLE 106 66 52 128
BYSTOLIC 104 71 54 137
EXELON 102 96 55 108
KLOR-CON 10 100 95 56 160
CARBIDOPA-LEVODOPA 99 91 57 97
PANTOPRAZOLE SODIUM 99 87 57 43
LANTUS 99 65 57 47
NOVOLOG FLEXPEN 97 73 60 169
HYDRALAZINE HCL 97 83 60 104
CEPHALEXIN 95 66 62 86
POLYETHYLENE GLYCOL 3350 95 75 62 55
GLIPIZIDE 94 83 64 67
AZITHROMYCIN 94 74 64 36
ALLOPURINOL 91 63 66 35
ISOSORBIDE MONONITRATE ER 86 80 67 45
MELOXICAM 85 72 68 34
CYCLOBENZAPRINE HCL 85 39 R 68 73
ISOSORBIDE DINITRATE 84 78 70 232
BENICAR 84 22 70 206
DICYCLOMINE HCL 83 25 72 202
BISOPROLOL-HYDROCHLOROTHIAZIDE 81 80 73 111
METOPROLOL SUCCINATE 80 56 74 19
LANSOPRAZOLE 79 50 75 140
KLOR-CON M10 78 64 76 138
OXYBUTYNIN CHLORIDE ER 78 38 76 79
PHENYTOIN SODIUM EXTENDED 77 49 78 126
SPIRIVA 74 62 79 57
LAMOTRIGINE 73 64 80 145
BUSPIRONE HCL 72 42 81 91
CARBAMAZEPINE 71 55 82 134
PROPRANOLOL HCL 71 27 82 136
TRICOR 71 27 82 132
ADVAIR DISKUS 70 45 85 58
LEVEMIR FLEXPEN 69 35 86 188
CIPROFLOXACIN HCL 69 52 86 56
NIFEDIPINE ER 68 61 88 154
MEGESTROL ACETATE 68 65 R 88 200
PAROXETINE HCL 68 45 88 60
LORAZEPAM 66 64 91 96
GLYBURIDE 66 65 R 91 62
ALENDRONATE SODIUM 65 49 93 26
OXAPROZIN 64 13 94 390
DILTIAZEM 24HR CD 64 40 94 124
BENZTROPINE MESYLATE 63 51 R 96 127
IBUPROFEN 63 41 96 74
ENABLEX 63 63 96 237
CLOZAPINE 62 49 99 170
PERPHENAZINE 61 46 100 234
HALOPERIDOL 61 49 100 147
OXYCODONE HCL 60 18 S2 102 72
PIOGLITAZONE HCL 60 42 R 102 274
LIDODERM 59 41 104 122
GEMFIBROZIL 59 23 104 117
TERAZOSIN HCL 58 54 106 135
MECLIZINE HCL 57 57 107 153
FENTANYL 56 30 S2 108 76
NOVOLOG 55 38 109 94
FLUOXETINE HCL 55 16 109 61
LIPITOR 55 49 109 100
METHOCARBAMOL 54 47 R 112 179
SINGULAIR 54 29 112 95
OLANZAPINE 52 44 114 106
CAPTOPRIL 52 47 114 371
DOXYCYCLINE HYCLATE 52 31 114 105
AMITIZA 51 43 117 288
TRIHEXYPHENIDYL HCL 51 51 R 117 330
CELEBREX 51 46 117 89
SEROQUEL 51 35 117 146
CLONAZEPAM 50 41 121 259
SUCRALFATE 50 41 121 164
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 12, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.